Source:http://linkedlifedata.com/resource/pubmed/id/12439038
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2002-11-19
|
| pubmed:abstractText |
To determine the efficacy and safety of low, nonescalating dose tissue plasminogen activator (rt-PA) in restoring the patency of occluded central venous access devices (CVCs) in children with cancer who weigh less than 30 kg.
|
| pubmed:language |
eng
|
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:author | |
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
653-6
|
| pubmed:dateRevised |
2011-10-6
|
| pubmed:articleTitle |
Use of tissue plasminogen activator (rt-PA) in young children with cancer and dysfunctional central venous catheters.
|
| pubmed:affiliation |
Department of Hematology/Oncology, Oakland Children's Hospital, 747 52nd Street, Oakland, CA 94609-1809, USA.
|